Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Ferlay J. et al. Corpus uteri. Global Cancer Observatory https://gco.iarc.who.int/media/globocan/factsheets/cancers/24-corpus-uteri-fact-sheet.pdf (International Agency for Research on Cancer, 2024).

Lortet-Tieulent, J., Ferlay, J., Bray, F. & Jemal, A. International patterns and trends in endometrial cancer incidence, 1978-2013. J. Natl Cancer Inst. 110, 354–361 (2018).

Article  PubMed  Google Scholar 

Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17–48 (2023).

Article  PubMed  Google Scholar 

Sung, H., Siegel, R. L., Rosenberg, P. S. & Jemal, A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public. Health 4, e137–e147 (2019).

Article  PubMed  Google Scholar 

Clarke, M. A., Devesa, S. S., Hammer, A. & Wentzensen, N. Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype. JAMA Oncol. 8, 895–903 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Spencer, R. J., Rice, L. W., Ye, C., Woo, K. & Uppal, S. Disparities in the allocation of research funding to gynecologic cancers by funding to lethality scores. Gynecol. Oncol. 152, 106–111 (2019).

Article  PubMed  Google Scholar 

Wan, Y. L. et al. Working together to shape the endometrial cancer research agenda: the top ten unanswered research questions. Gynecol. Oncol. 143, 287–293 (2016).

Article  PubMed  Google Scholar 

Donkers, H., Bekkers, R., Massuger, L. & Galaal, K. Systematic review on socioeconomic deprivation and survival in endometrial cancer. Cancer Causes Control. 30, 1013–1022 (2019).

Article  CAS  PubMed  Google Scholar 

Jamison, P. M., Noone, A. M., Ries, L. A., Lee, N. C. & Edwards, B. K. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol. Biomark. Prev. 22, 233–241 (2013).

Article  Google Scholar 

Bregar, A. J. et al. Disparities in receipt of care for high-grade endometrial cancer: a National Cancer Data Base analysis. Gynecol. Oncol. 145, 114–121 (2017).

Article  PubMed  Google Scholar 

Madison, T., Schottenfeld, D., James, S. A., Schwartz, A. G. & Gruber, S. B. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am. J. Public. Health 94, 2104–2111 (2004).

Article  PubMed  PubMed Central  Google Scholar 

Najor, A. et al. Disparities in timeliness of endometrial cancer care: a scoping review. Obstet. Gynecol. 142, 967–977 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Henley, S. J., Miller, J. W., Dowling, N. F., Benard, V. B. & Richardson, L. C. Uterine cancer incidence and mortality – United States, 1999-2016. MMWR Morb. Mortal. Wkly. Rep. 67, 1333–1338 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Cook, L. S. et al. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control. 24, 61–69 (2013).

Article  PubMed  Google Scholar 

Zhang, M. M. et al. Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors. Obstet. Gynecol. 107, 329–335 (2006).

Article  PubMed  Google Scholar 

Whetstone, S. et al. Health disparities in uterine cancer: report from the uterine cancer evidence review conference. Obstet. Gynecol. 139, 645–659 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Bokhman, J. V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15, 10–17 (1983).

Article  CAS  PubMed  Google Scholar 

Felix, A. S. et al. Factors associated with type I and type II endometrial cancer. Cancer Causes Control. 21, 1851–1856 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579–591 (2004).

Article  CAS  PubMed  Google Scholar 

Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569–578 (2008).

Article  PubMed  Google Scholar 

Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384, 755–765 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Bjorge, T., Engeland, A., Tretli, S. & Weiderpass, E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int. J. Cancer 120, 378–383 (2007).

Article  PubMed  Google Scholar 

McCullough, M. L. et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol. Biomark. Prev. 17, 73–79 (2008).

Article  CAS  Google Scholar 

Lu, K. H. et al. Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J. Clin. Oncol. 25, 5158–5164 (2007).

Article  CAS  PubMed  Google Scholar 

Hampel, H. et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 66, 7810–7817 (2006).

Article  CAS  PubMed  Google Scholar 

Dominguez-Valentin, M. et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet. Med. 22, 15–25 (2020).

Article  CAS  PubMed  Google Scholar 

Gupta, S. et al. Genetic/familial High-risk Assessment: Colorectal, Version 2.2023. NCCN Guidelines (National Comprehensive Cancer Network, 2023).

Russo, M. et al. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma. Hum. Pathol. 67, 69–77 (2017).

Article  PubMed  Google Scholar 

WHO Classification of Tumours Editorial Board. Female Genital Tumours (WHO Classification of Tumours, 5th edn, Vol. 4) (International Agency for Research on Cancer, 2020).

Zaino, R. J., Kurman, R. J., Diana, K. L. & Morrow, C. P. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study. Cancer 75, 81–86 (1995).

Article  CAS  PubMed  Google Scholar 

Bogani, G. et al. Uterine serous carcinoma. Gynecol. Oncol. 162, 226–234 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ambros, R. A., Sherman, M. E., Zahn, C. M., Bitterman, P. & Kurman, R. J. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum. Pathol. 26, 1260–1267 (1995).

Article  CAS  PubMed  Google Scholar 

Zheng, W., Xiang, L., Fadare, O. & Kong, B. A proposed model for endometrial serous carcinogenesis. Am. J. Surg. Pathol. 35, e1–e14 (2011).

Article  PubMed  Google Scholar 

Slomovitz, B. M. et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol. Oncol. 91, 463–469 (2003).

Article  PubMed  Google Scholar 

Huang, C. Y. et al. Impact of management on the prognosis of pure uterine papillary serous